Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001181431-13-051049
Filing Date
2013-09-30
Accepted
2013-09-30 16:14:17
Documents
2
Period of Report
2013-09-30

Document Format Files

Seq Description Document Type Size
1 rrd391619.html 3  
1 rrd391619.xml 3 1582
2 EXHIBIT 24 - POWER OF ATTORNEY rrd352339_399018.htm EX-24. 2782
  Complete submission text file 0001181431-13-051049.txt   5872
Mailing Address C/O IMMUNOGEN, INC. 830 WINTER ST. WALTHAM MA 02451
Business Address
PERRY GREGORY D (Reporting) CIK: 0001236371 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-52089 | Film No.: 131123469

Mailing Address ONE KENDALL SQUARE BUILDING 1400 EAST 4TH FLOOR CAMBRIDGE MA 02139
Business Address ONE KENDALL SQUARE BUILDING 1400 EAST 4TH FLOOR CAMBRIDGE MA 02139 617-863-5524
INVIVO THERAPEUTICS HOLDINGS CORP. (Issuer) CIK: 0001292519 (see all company filings)

EIN.: 000000000 | State of Incorp.: NV | Fiscal Year End: 1231
SIC: 3841 Surgical & Medical Instruments & Apparatus